Dr. Larry Bernstein has reached an MD degree and has dedicated his entire professional career to a large spectrum of clinical and research activities aiming at improving the health status of hospitalized patients. He has manifested continuing interest in laboratory methods currently used in clinical pathology, clinical chemistry, and human nutrition, allowing to detect and to treat several diseased states. He has published an impressive number of scientific papers along these lines, focusing more attention on these biochemical parameters assessing the risk of respiratory insufficiency in newborn babies (the surfactant/albumin ratio), staging Several Cancer morbidities (CEA, CA 125, PSA), allowing the early detection and follow-up of myocardial infarction (troponin T) and of malnourished patients (transthyretin, TTR). In addition, he has developed statistical methods using the ordinal logit regression model integrating and classifying laboratory results with a view to improve risk assignment. Finally, he has performed original economic studies, notably in collaboration with experts of the Center of Disease Control (Atlanta) to evaluate the correlations linking early diagnosis and aggressive nutritional support of malnourished patients with the shortening of their hospital stay and the corresponding cost savings. From a scientific standpoint, Dr. Larry Bernstein occupies an original position amongst the best clinical chemists and nutritionists. Some of the research topics that he has developed are also subjected to intense investigations by other workers in the USA and elsewhere but seen from abroad, the outstanding advances that he has provided on behalf of TTR as an analytical tool for the diagnosis and prognosis of malnutrition are worthy of the largest consideration.
Gene Expresison, Cancer Biology, Molecular Biology, Genomics, Nutrition, Biotechnology, Cardiovascular Medicine, Biomedical Sciences, Biochemistry, Data Analysis
Dr. Basina is a clinical endocrinologist at Stanford University Medical Center and clinical researcher with a focus on diabetes management and diabetes technology. Her primary interests are in Type 1 Diabetes, Diabetes technology, and Diabetes in pregnancy. She graduated from Moscow Medical School in Russia in 1987 with summa cum laude, moved to the US in 1991. Completed her residency in internal medicine at the University of California in Los Angeles and fellowship in Endocrinology at Stanford University. Dr. Basina worked at Kaiser Permanente for the first 5 years after fellowship as a staff endocrinologist and core clinical faculty of Internal Medicine Residency Program. She joined Stanford University as a full-time faculty in 2008 and has been working there since. She has a busy clinical practice at Stanford Hospital and Clinics seeing patients in both inpatient and outpatient settings. She serves as medical director of inpatient diabetes service at Stanford. Dr. Basina received numerous teaching awards and a Stanford Hospital award for excellence in patient care. She leads support groups for individuals with type 1 diabetes. She is an active member of the medical advisory board for Community diabetes, gives educational talks for patients on a regular basis. From the research perspective, she served as a primary investigator in several studies Like Rosiglitazone-Induced weight gain, the study comparing two different insulin regimens for Diabetes control and for prevention of hypoglycemia in patients undergoing Hemodialysis with End Stage Renal disease due to complications from Diabetes. Dr. Basina was a co-investigator on the NIH-sponsored research study of Safety and Efficacy of Sensor-Augmented Continuous Subcutaneous Insulin Infusion in Patients with Diabetic Gastroparesis. She is currently a primary investigator on Novo Nordisk sponsored trial comparing Tresiba and Toujeo insulin, co-investigator on ECHO project funded by Helmsley trust fund aimed at an improvement of medical care for type 1 diabetes in underserved areas, also a co-investigator on the use of 670G hybrid closed-loop Medtronic insulin pump as a prospective follow up of the patients.
Type 1 Diabetes, Diabetes Technology, Diabetes in Pregnancy
Dr. Sumeet Gupta working as Professor & Head, Pharmacology, M. M. College of Pharmacy, M. M. University (NAAC “A” grade Deemed University), Mullana, Ambala, Haryana accredited by Scientific and Industrial Research Organization under Department of Science and Technology, Ministry of Science and Technology, Government of India. He was awarded the degree of Doctor of Philosophy (Ph.D.) under the faculty of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar (‘A’ Grade by NAAC, Centre with Potential for Excellence in Particular Area) for his thesis entitled “Pharmacogenomics of antihypertensive therapy in the rural population of Haryana”. His main research interest includes the scientific validation of plant-based compounds in the treatment of metabolic disorders includes complications. Dr. Sumeet has more than 14 years of teaching and research experience in the area of “Preclinical and Clinical Pharmacology”. He has published various research & review articles with high thomsun ruter impact factor in peer review National and International Journals. He has also published 2 books and one chapter with International Publishers. He has filed 11 patents in India. His research work was also nominated in Indian Pharmacological Society during 2011-2012. He was also organized as an Organizing secretary in North Zone Indian Pharmacological Society conference sponsored by the Medical Council of India, Department of Biotechnology, and two industries (Cipla Pharmaceuticals and Rolex equipment) which was held in M M University on October 2014. Dr. Gupta was also awarded under “International Travel Support Scheme” by the Department of Science and Technology, Government of India, New Delhi to attend and poster presentation in the 2nd International Pharm-nutrition conference at Singapore 15 April 2013-17 April 2013. He was received Bursary Award by Elsevier publishers, the United Kingdom for his best nutraceutical research in Pharm-nutrition conference. Additionally, he has received International support travel grant from the centre for International Co-operation in Science. He was received Jewel of India award in New Delhi for his academic excellence. He has got collaborated with CPEPA project on “diabetes” with Guru Nanak Dev University, Amritsar. He has collaborated with three International Universities (King Faisal University, Oman University, and Shaqra University) and Indian reputed Universities (Punjab University, Guru Nanak Dev University, Uttaranchal Technical University and Punjab Technical University). He is also actively collaborated with IIT Roorkee. He is also the life member of many societies like APTI, IPS, IPA, IHPA, ISPOR & ACS. He is also serving as Associate Editor of GJPS, besides; he is also the member of the reviewer of many reputed scientific international journals like Pharmaceutical Biology, International J of Diabetes in Developing countries, J of Publish health, Current Pharmaceutical Design, Current Drug Therapy and Natural Product Research. His research work also shortlisted for research ward grant under University Grant Commission.
Type 1 Diabetes, Diabetes Technology, Diabetes in Pregnancy